LncRNA MALAT1 promotes colorectal cancer development by sponging miR-363-3p to regulate EZH2 expression
Authors: W H Li
X Li
J J Xie
C F Shao
W Ye
Journal: Journal of biological regulators and homeostatic agents (0)
Discipline: BIOLOGY & BIOCHEMISTRY
Keywords: Cancer development; Colorectal cancer; EZH2; MALAT1; miR-363-3p.
Affiliations: Department of Anorectal Surgery, The First People's Hospital of Wenling, Zhejiang Province, China., Department of General Surgery, The First People's Hospital of Wenling, Zhejiang Province, China.

Abstract:  LncRNA MALAT1 is reported to play a potential role in human cancers. Hence, we investigated the effects of MALAT1 on colorectal cancer in vitro and in vivo, and further validated whether MALAT1 affected colorectal cancer development and EZH2 expression via regulating miR-363-3p. The fresh colorectal cancer tissues, adjacent non-tumor tissues, FHC, LOVO, SW620, CL40 and HCT116 cells were analyzed in this study. MALAT1, miR-363-3p and EZH2 expression levels were assessed using qRT-PCR and Western blot. Cell proliferation, migration and invasion were also measured. Binding effects between MALAT1 and miR-363-3p, or miR-363-3p and EZH2 3'UTR were detected by dual luciferase assay. We observed that MALAT1 was highly expressed in colorectal cancer tissues and cells, and MALAT1 knockdown inhibited cell proliferation as well as expression levels of EZH2 by upregulated miR-363-3p in cell models and in vivo. Moreover, miR-363-3p functions as a downstream target of MALAT1, meanwhile EZH2 was a target of miR-363-3p, suggesting MALAT1 might regulate miR-363-3p and/or EZH2 expression. Collectively, we concluded that MALAT1 functioned as a ceRNA to promote colorectal cancer development and EZH2 expression through sponging miR-363-3p in vitro and in vivo. 

Retracted: No

PubPeer comments:
 Fig. 2. ...  c Expression of nephrin studied by immunofluorescence. Tissue sections were immunostained with the antinephrin antibody and an FITC-conjugated secondary antibody (green). The Legend is not explicit about the identities of panels A to D, but the main text explains that  CCD group ... ( fig. 2 c, A)... FCD group ( fig. 2 c, B) ...the FSD group... ( fig. 2 c, C). ... the CSD group ( fig. 2 c, D) .  2 cB and 2cD seem to be the same image with different levels of contrast and brightness. , 
 [Right] Fig 3. The text explains that  The CSD [control soy protein] group ( fig. 3 d) shows normal podocyte and basement membrane structure. [Left] Fig. 5.(au2013d) from [Nallasamy Palanisamy Anuradha C. Venkataraman (2013)] .  Transmission electron microscopic examination of rat kidney (x 10 000). (a) An electron micrograph from a control rat. Regularly arranged podocyte foot processes with normal basement membrane are observed. (b) An electron micrograph from a fructose-fed rat. Abnormal foot processes effacement, podocyte appear broadened, basement membrane thickening and extensive deposition of matrix proteins (blue arrows) are seen. **(c) An electron micrograph from a genistein-treated fructose-fed rat shows basement membrane within normal limits; some podocyte foot processes appear broadened.** (d) Electron micrograph from a genistein-treated control rat shows normal structure of podocytes and basement membrane.  Could the authors clarify whether the boxed panel(s) was treated with genistein fructose, or soy protein? , 
 Fig. 1.  a mRNA expression of collagen type-IV, MMP-2, TIMP-2, TNF- and VEGF. Darkened, contrast-enhanced version at right.  The actin control blobs all seem to be identical copies, which reduces their value for normalisation. Some other similarities in other bands are also marked with coloured cartouches. ,